AbbVie Inc. v. Hetero USA, Inc. et al
Delaware District Court | |
Judge: | Maryellen Noreika |
Case #: | 1:25-cv-00190 |
Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
Cause | 35:271 Patent Infringement |
Case Filed: | Feb 14, 2025 |
Last checked: Wednesday Feb 19, 2025 2:06 AM EST |
Defendant
Hetero Labs Limited
|
|
Defendant
Hetero Labs Limited Unit-V
|
|
Defendant
Hetero USA, Inc.
|
|
Defendant
Hoster Labs Private Limited
|
|
Plaintiff
AbbVie Inc.
|
Represented By
|
Docket last updated: 02/20/2025 11:59 PM EST |
Wednesday, February 19, 2025 | ||
utility
Case Assigned/Reassigned
Wed 02/19 12:21 PM
Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms) |
||
Tuesday, February 18, 2025 | ||
utility
- CORRECTING ENTRY
Tue 02/18 9:45 AM
CORRECTING ENTRY: The main document and attachment documents at D.I.6 have been modified and replaced to reflect the correct day of issuance. (cdd) |
||
Friday, February 14, 2025 | ||
6 | 6
![]() Summons Issued as to Hetero Labs Limited on 2/18/2025; Hetero Labs Limited Unit-V on 2/18/2025; Hetero USA, Inc. on 2/18/2025; Hoster Labs Private Limited on 2/18/2025.(cdd) |
|
Att: 1
![]() |
||
Att: 2
![]() |
||
Att: 3
![]() |
||
5 | 5
![]() Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc. (cdd) |
|
4 | 4
![]() Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,607,411 B2; 11,564,922 B2. (cdd) |
|
3 | 3
![]() Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/6/2025. Date of Expiration of Patent: 3/9/2038. Thirty Month Stay Deadline: Not earlier than 8/6/2027. (cdd) Modified on 2/18/2025 (nms) |
|
2 | 2
![]() Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) |
|
1 | 1
![]() COMPLAINT against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc., Hoster Labs Private Limited (Filing fee $ 405, receipt number ADEDC-4615717) - filed by AbbVie Inc..(cdd) |
|
Att: 1
![]() |
||
Att: 2
![]() |
||
Att: 3
![]() |